Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Buy Coinbase Stock Now as Crypto Prices Rocket Back to the Moon

With cryptocurrencies trading at their highest levels since before the 2022 bear market, the stock of crypto exchange Coinbase Global is once again flying high.

Analyst Upgrades: 3 Stocks That Just Got a Boost From Wall Street

After strong prints, some previously unloved stocks are now seeing some welcome upgrades from analysts after years of being downgraded or neglected.

The 3 Best Dividend Stocks Under $10 to Buy Now

Embrace the potential of best dividend stocks under $10, combining excitement with diligence for a robust, diversified investment strategy.

The 3 Most Popular Stocks Owned by Congress in Q1

Sometimes, the best trading advice can come from a list of stocks owned by Congress. If they are buying it could be worth checking out.

7 Stocks That Google’s Updated AI Wants You to Buy

Google's updated Gemini AI model reveals its latest stocks to buy. Let's analyze the pros and cons of its recommendations.

3 Game-Changing Stocks to Double Your Money by 2026

These game-changing stocks can unlock investment growth in just a short time using transformative technology.

3 Charged-Up Battery Stock Picks You Don’t Want to Miss

The International Energy Agency predicts that “installed battery capacity worldwide will increase tenfold to sixteenfold by 2030.” McKinsey believes that 120 to 150 new battery…

3 Juggernaut Stocks for Sustained Portfolio Strength

With our economy heading on a very strong path, these stocks to buy are ripe to reward your portfolio with profits.

3 Breakout Stocks to Buy BEFORE They Take Flight

There are a lot of breakout stocks right now with potentially more runway than the semiconductor industry's hottest names.

The Cash Flow Kings: 3 Dividend Stocks With Bulletproof Financials

If you are looking for yield, these dividend stocks count with bulletproof balance sheets and free cash flow to afford them.

3 Penny Stocks Primed to Create a New Wave of Millionaires

These undervalued penny stocks seem primed for explosive gains in 2024 and beyond. Consider getting in on these potential winners.

3 Bargain Stocks to Snatch Up Before They Bounce Back

The market is a weighing machine in the long run, meaning these bargain stocks will deliver impressive forward returns.

The Golden Years: 7 Dividend Champions to Secure Your Retirement

Dividend Champions allow investors to receive extra cash without doing any additional work. Once you analyze a stock and decide it's a good long-term investment,…

3 Contrarian Stock Picks to Outsmart Wall Street in 2024

Contrarian stocks can be quite profitable because the Street is often far too pessimistic about the outlook of many individual equities. 

Have One Dollar? 3 Stocks to Buy and Hold Forever.

Looking for penny stocks under $1? These three high-risk, high-reward stocks could deliver huge returns for opportunistic investors.

3 Vice Stocks That Can Make a Gloomy February Sizzle

We’re all thinking about it but we don’t say it out loud – that’s the underlying theme behind vice stocks. During an economically challenging cycle,…

3 Tech Penny Stocks That Could Become Tomorrow’s Giants

While digital innovation is all the rage, the underlying companies’ lofty valuations incentivizes a closer look at tech penny stocks. Of course, this sector presents…

7 Defensive Stocks to Weather Any Downturn With Ease

With the Dow Jones closing at a fresh record recently, targeting defensive stocks might seem like overkill. You want to be careful in the capital…

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

While biotech stocks offer some of the most pertinent ideas available in the market, they can be awfully risky. One bad clinical result and boom…